ClinicalTrials.govpublic full text
Characterization of Intramuscular Injections of Risperidone 4 Week Long-acting Injectable (LAI) Formulation in the Buttock of Patients With Schizophrenia
psychotic disorders, schizophrenia, risperidone, antipsychotic, pharmacokinetic, long-acting injectable, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 812822
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.